Identification of Isomerically Diverse Ginsenosides Using Engineered Aerolysin Nanopore via Non-Translocation Blockade Sensing.

Journal: Angewandte Chemie (International ed. in English)
Published Date:

Abstract

Typical nanopore sensing depends on slowed translocation through the pore to acquire effective blockade signals. However, this paradigm often suffers from low signal precision and poor resolution, making it challenging to resolve pools of analytes with diverse, similar structures. Here, we present a non-translocation blockade sensing based on an engineered aerolysin S278K that enables the identification of isomerically diverse ginsenosides-a class of glycoconjugates whose structural characterization has been a persistent challenge in glycoscience. By introducing the S278K mutation, the aerolysin acquires a highly positively charged interior and generates intense electro-osmotic flow and enhanced steric/enthalpic barriers, effectively trapping ginsenoside molecules in the K278-R220 region and preventing their further translocation. This distinct blockade sensing mode significantly improves the detection capability of aerolysin by prolonging residence time (e.g., 43-fold longer), enabling detailed molecular characterization. As a result, we demonstrate the unambiguous identification of 30 ginsenosides differing in glycosyl composition, isomerism, modification, and aglycone, as well as the quantitative analysis of complex ginsenosides in real samples by integrating deep learning. This work underscores the promise of non-translocation nanopore sensing for deciphering structurally complex and diverse small molecule analytes.

Authors

  • Jing Wang
    Endoscopy Center, Peking University Cancer Hospital and Institute, Beijing, China.
  • Minmin Li
    Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province, Department of Chemistry, Northeast Normal University, 5268 Renmin Street, Changchun, 130024, Jilin, China.
  • Chen Zhang
    Department of Dermatology, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Xinjia Zhao
    State Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, P. R. China.
  • Yuting Xiong
    State Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, P. R. China.
  • Yuchen Cao
    Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100144, China.
  • Dongdong Wang
    Department of Radiology, Huashan Hospital Affiliated to Fudan University, 12 Wulumuqi Rd. Middle, Shanghai 200040, China.
  • Xiaonong Li
    Jiangxi Provincial Key Laboratory for Pharmacodynamic Material Basis of Traditional Chinese Medicine, Ganjiang Chinese Medicine Innovation Center, Nanchang 330000, P. R. China.
  • Xinmiao Liang
    Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China. Electronic address: liangxm@dicp.ac.cn.
  • Guangyan Qing
    State Key Laboratory of Medical Proteomics, National Chromatographic R. & A. Center, CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, P. R. China.